Shandong Xinhua Pharmaceutical (000756.SZ) obtained the registration certificate for Fumarate Bisoprolol Tablets.

Shandong Xinhua Pharmaceutical (000756.SZ) announced that the company has received the approved and issued Drug Registration Certificate for metoprolol succinate tablets from the National Medical Products Administration. The announcement states that metoprolol succinate tablets are indicated for hypertension, coronary heart disease (angina), and chronic stable heart failure with reduced left ventricular ejection fraction (35%). When using this product, it is necessary to follow medical advice and receive treatment with ACE inhibitors, diuretics, and selective use of cardiac glycosides.